Thrombogenic materials in prothrombin complex concentrates.
about
Binding of human factor VII and VIIa to monocytesA novel one-step purification of human alpha-thrombin after direct activation of crude prothrombin enriched from plasma.Viral safety of haemophilia treatment products.Factor IX and thrombosis.Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulationIn vitro and in vivo correlation of clotting protease activity: effect of heparin.The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activityAn observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergenciesThe clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency.Prothrombin complex concentrates for oral anticoagulant therapy-related intracranial hemorrhage: a review of the literature.First 20 years with recombinant FVIIa (NovoSeven).Current options and new developments in the treatment of haemophilia.Disseminated intravascular coagulation in cirrhosis.Prothrombin complex concentrates: clinical use.Prothrombin complex concentrates for clinical use.Assessment of thrombogenicity of activated and non-activated prothrombin concentrates in a rat model.Kinetics of factor IX activity differ from that of factor IX antigen in patients with haemophilia B receiving high-purity factor IX replacement.Danazol therapy in factor X deficiency.Thrombogenicity of factor IX concentrates: in vitro and in vivo (rabbit) studies.A new treatment strategy for hemophilia B: incorporation of factor IX into red cell ghosts.Coagulation factor IX concentrate: historical perspective.Safety of coagulation factor concentrates.Coronary artery bypass grafting in a patient with haemophilia B.Activated factor VII: my story.Coagulation factor IX: successful surgical experience with a purified factor IX concentrate.Disseminated intravascular coagulation and hemorrhage in hemophilia B following elective surgery.The use of continuous infusion of factor concentrates in the treatment of hemophilia.Porcine factor VIII and plasmapheresis in the management of hemophiliac patients with inhibitors.
P2860
Q28631055-8FEEC39F-FF3E-4033-BDC9-3E3582E5C2F7Q33291277-995C983A-94D3-44B8-A456-41F26B7911CCQ34087439-46AB60D4-A1BA-4AD7-8285-E04EB08939BDQ34104373-5956EB14-B675-4271-8A88-D50BC67A5003Q34623120-85F09885-6A13-4FFC-9102-02F6B2B64167Q35038341-FFC1CFEA-49EA-49BD-B376-EC8F6F2DE89CQ35905116-57EA471A-CE4B-44F0-8B1E-0BC6A6F9B6BFQ36366940-F9974D26-FB14-46BD-AC79-E67445934F56Q37468659-AF754877-6FA0-4217-A228-166C1486D63DQ37646452-581ABD51-8668-4AAB-BF6C-27A61EF22F0FQ37770599-443C7E6B-DD37-43E6-8AD7-8A126D36F3AFQ37841547-6117B2CC-3EEA-4209-B16E-6EFFF87A2693Q38650549-D8D72B4E-156E-49E7-93E3-166BCA45E035Q40261651-AE0A3117-4FAC-4FF0-8EB7-36D150B662A7Q40263219-39561AAE-3053-4706-96B1-BB77A79311C3Q41558828-EDEEC3C3-4863-44D8-B430-121AB81B73E2Q41684822-03CFA8EC-4E19-44F1-A569-4BBA898A868CQ43736003-CBA7C114-85E7-4523-9EE0-CCF9E59D0B6DQ43967315-E7FEAC2D-22A9-456B-997D-408623D1CC58Q44463981-F6025CD9-00FA-43D3-AEE5-B011FFD145C4Q45034652-C329A337-636F-424C-942C-3CA341BA03ECQ45854895-6D1C4883-389A-41CE-BD7E-ECFBFD678FE6Q45865943-E56FF885-8E8B-485C-B3D8-F41B91804F0DQ45877085-DF79C4F6-914D-4723-8B7B-BA709E7F2144Q45880224-61673844-5A8F-4DD5-91F1-EE10F3ADAE58Q45883033-7B44350C-EA8E-4F91-82B4-8964BF7D65DEQ45884002-6432353E-40B4-47D4-A854-3E77C7E44F8FQ45886725-C8E3610C-D9EE-4C99-979E-634BCA2166A3
P2860
Thrombogenic materials in prothrombin complex concentrates.
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh-hant
name
Thrombogenic materials in prothrombin complex concentrates.
@en
Thrombogenic materials in prothrombin complex concentrates.
@nl
type
label
Thrombogenic materials in prothrombin complex concentrates.
@en
Thrombogenic materials in prothrombin complex concentrates.
@nl
prefLabel
Thrombogenic materials in prothrombin complex concentrates.
@en
Thrombogenic materials in prothrombin complex concentrates.
@nl
P2093
P1476
Thrombogenic materials in prothrombin complex concentrates.
@en
P2093
P304
P356
10.7326/0003-4819-81-6-766
P407
P577
1974-12-01T00:00:00Z